Analysis of patient immune parameters has linked disease severity to elevated levels of biomarkers for inflammation (C-reactive protein [CRP] and cardiac troponin I), organ damage (aspartate aminotransferase [AST] and hypoalbuminemia), immune hyperactivity (interleukin-6 [IL-6] and IL-10), and clotting (d-dimer) (4). The gene discussed is CRP; the disease is Hypoalbuminemia.